DMARDs typically target the immune cells that are responsible for inflammatory responses. For instance, methotrexate, a commonly used DMARD, inhibits the metabolism of folic acid, which is crucial for DNA synthesis and cell division. This leads to a reduction in the proliferation of lymphocytes, thereby decreasing the immune response.
